Teachers Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-1,321
Closed -$139K 3097
2018
Q1
$139K Hold
1,321
﹤0.01% 2927
2017
Q4
$169K Hold
1,321
﹤0.01% 2959
2017
Q3
$153K Sell
1,321
-175
-12% -$21K ﹤0.01% 3005
2017
Q2
$195K Buy
+1,496
New +$202K ﹤0.01% 3012

Other funds holding VBIV

Teachers Advisors's VBIV Position: Q2 2018 in Review

Teachers Advisors sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2018, closing a stake of 1,321 shares — an estimated $139K sold.

Teachers Advisors first reported a position in VBIV in Q2 2017 and held it in 4 quarters. The position peaked at $195K in Q2 2017. 48 funds tracked by Wall St. Rank hold VBIV as of Q2 2018.

  • Teachers Advisors reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2018 after selling out during the quarter.
  • Teachers Advisors sold 1,321 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2018, an estimated $139K.
  • Teachers Advisors first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2017 and held it in 4 quarters.
  • Teachers Advisors's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $195K in Q2 2017.
  • 48 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2018.

Based on Teachers Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.